Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 May;41(5):582-586.
doi: 10.1007/s12055-024-01834-2. Epub 2024 Nov 11.

Cold agglutinin disease coexisting with left main coronary artery involvement and ventricular dysfunction - a challenging triad

Dhiren Shah  1 , Kishore Gupta  1 , Ankit Jitani  2 , Dhaval Naik  1 , Chintan Sheth  3
Affiliations
Case Reports

Cold agglutinin disease coexisting with left main coronary artery involvement and ventricular dysfunction - a challenging triad

Dhiren Shah et al. Indian J Thorac Cardiovasc Surg. 2025 May.

Abstract

Cold hemagglutinin disease (CHAD) is a rare autoimmune condition characterized by cold-reactive antibodies causing hemagglutination and complement-mediated hemolysis. This case report details the successful management of a 56-year-old male with CHAD, coronary artery disease, and left ventricular dysfunction. The patient underwent coronary artery bypass grafting (CABG) amid challenges, including a rapid drop in hemoglobin levels, limited compatible blood supply, and cardiac comorbidities. Treatment involved rituximab, bortezomib, and a meticulous perioperative protocol to prevent hypothermia. The multidisciplinary approach, including hematologists, anesthetists, and surgeons, played a crucial role in managing the triad highlighting the importance of tailored management in CHAD cases.

Keywords: Cold hemagglutinin disease; Cold-reactive antibodies; Coronary artery bypass grafting.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestNone.

Similar articles

See all similar articles

References

    1. Barbara DW, Mauermann WJ, Neal JR, Abel MD, Schaff HV, Winters JL. Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2013;146:668–80. - PubMed
    1. Wintrobe MM, Greer JP. Wintrobe’s Clinical hematology. 12th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.
    1. Agarwal SK, Ghosh PK, Gupta D. Cardiac surgery and cold-reactive proteins. Ann Thorac Surg. 1995;60:1143–50. - PubMed
    1. Zoppi M, Oppliger R, Althaus U, Nydegger U. Reduction of plasma cold agglutinin titers by means of plasmapheresis to prepare a patient for coronary bypass surgery. Infusionsther Transfusionsmed. 1993;20:19–22. - PubMed
    1. Röth A, Barcellini W, D’Sa S, Miyakawa Y, Broome CM, Michel M, et al. Sutimlimab in cold agglutinin disease. N Engl J Med. 2021;384:1323–34. - PubMed

Publication types